1e
19
1
49
2
2
18
1b
1d
18
37
79
1d
2 29
1d
25
Carmela C. Vittorio, M.D.
88
79
Associate Professor of Dermatology at the Hospital of the University of Pennsylvania
28
97
3
62
Staff Dermatologist- Consult and Inpatient Attending, Hospital of the University of Pennsylvania
91
Chair Residency Selection Committee, Department of Dermatology, University of Pennsylvania
ab
Member, EPIC Governance Committee, Department of Dermatology, University of Pennsylvania Perelman School of Medicine
a6
Quality Assessment Committee, Department of Dermatology, University of Pennsylvania Perelman School of Medicine
7d
Staff Dermatologist Consult and Attending, Presbyterian Medical Center
77
Staff Dermatologist Consult and Attending, Pennsylvania Hospital
89
Director of Medical Imaging, Department of Dermatology, University of Pennsylvania
11
Department: Dermatology
4
1
b
1d
46
Contact information
48
4
3
3
3
2
4
b
1f
48
University of Pennsylvania
23 Perelman School of Medicine
21 Department of Dermatology
11 2 Maloney
35 3600 Spruce Street
Philadelphia, PA 19104
26
23 Perelman School of Medicine
21 Department of Dermatology
11 2 Maloney
35 3600 Spruce Street
Philadelphia, PA 19104
2e
Office: 215-662-2589
30
f
30
13
Education:
21 7 BA 17 (Psychology) c
28 Pace University, 1976.
21 5 18 (Pre Medical) c
2c Columbia University, 1981.
21 5 18 (Pre-Medical) c
28 Pace University, 1983.
21 9 M.D. c
33 University of Pennsylvania, 1989.
c
3
3
3
3
8b
Permanent link21 7 BA 17 (Psychology) c
28 Pace University, 1976.
21 5 18 (Pre Medical) c
2c Columbia University, 1981.
21 5 18 (Pre-Medical) c
28 Pace University, 1983.
21 9 M.D. c
33 University of Pennsylvania, 1989.
c
2 29
21
1e
1d
24
2b
29
27
23
170 McGinnis KS, Junkins-Hopkins JM, Crawford G, Shapiro M, Rook AH, Vittorio CC: Low dose oral bexarotene in combination with low dose interferon alpha in the treatment of cutaneous T-cell lymphoma: Clinical synergism and possible immunologic mechanisms. J Amer Acad Dermatol 50(3): 375-379, 2004.
11e McGinnis KS, Ubriani R, Newton S, Junkins-Hopkins JM, Vittorio CC, Wysocka M, Rook AH: The addition of interferon gamma to oral bexarotene therapy with photopheresis. Arch Dermatol 141(9): 1176-1178, 2005 Notes:
14d Richardson SK, McGinnis KS, Shapiro M, Lehrer MS, Kim EJ, Vittorio CC, Junkins Hopkins JM, Rook AH: Extracorporeal photopheresis and multimodality immunomodulatory therapy in the treatment of cutaneous T-Cell lymphoma. J Cutan Med Surg E-pub, September, 2003.
14b Richardson SK, McGinnis KS, Shapiro M, Lehrer MS, Kim EJ, Vittorio CC, Junkins Hopkins JM, Rook AH: Extracorporeal Photopheresis and Multimodality Immunomodulatory Therapy in the Treatment of Cutaneous T-Cell Lymphoma. J Cutan Med Surg 2004 Notes: In Press.
113 Lehrer MS, Crawford G, Gelfand J, Leyden JJ, Vittorio CC: The effect of wax epilation prior to hair removal with a long-pulsed alexandrite laser – a pilot study. J Dermatologic Surg 29: 118-123, 2003.
143 Prins C, Vittorio C, Padilla RS, Hunziker T, Itin P, Forster J, Brocker ED, Saurat JH, French LE: Effect of high-dose intravenous immunoglobulin therapy in Stevens-Johnson syndrome: a retrospective, multicenter study. Dermatology 207(1): 96-99, 2003.
134 Gelfand JM, Wasik MA, Vittorio CC, Rook AH, Junkins-Hopkins JM: Progressive epidermotropic primary cutaneous CD30+, CD8+ anaplastic large T-cell lymphoma in a patient with sarcoidosis. J Amer Acad Dermatol 51(2): 304-308, 2004 Notes:
14d Shapiro M, Wasik MA, Junkins-Hopkins JM, Rook AH, Vittorio CC, Itakura H, Frankel MC, Georgala S, Schuster SJ: Complete remission in advanced blastic NK-cell lymphoma/leukemia in elderly patients using the Hyper-CVAD regimen. Amer J Hematol 74(1): 46-51, 2003.
2c
7
1d
1f
Selected Publications
d9 Hivnor C, Shapiro M, Vittorio CC: Intravenous cidofovir for recalcitrant verruca vulgaris in the setting of HIV. Arch Dermatol 140: 13-14, 2004.170 McGinnis KS, Junkins-Hopkins JM, Crawford G, Shapiro M, Rook AH, Vittorio CC: Low dose oral bexarotene in combination with low dose interferon alpha in the treatment of cutaneous T-cell lymphoma: Clinical synergism and possible immunologic mechanisms. J Amer Acad Dermatol 50(3): 375-379, 2004.
11e McGinnis KS, Ubriani R, Newton S, Junkins-Hopkins JM, Vittorio CC, Wysocka M, Rook AH: The addition of interferon gamma to oral bexarotene therapy with photopheresis. Arch Dermatol 141(9): 1176-1178, 2005 Notes:
14d Richardson SK, McGinnis KS, Shapiro M, Lehrer MS, Kim EJ, Vittorio CC, Junkins Hopkins JM, Rook AH: Extracorporeal photopheresis and multimodality immunomodulatory therapy in the treatment of cutaneous T-Cell lymphoma. J Cutan Med Surg E-pub, September, 2003.
14b Richardson SK, McGinnis KS, Shapiro M, Lehrer MS, Kim EJ, Vittorio CC, Junkins Hopkins JM, Rook AH: Extracorporeal Photopheresis and Multimodality Immunomodulatory Therapy in the Treatment of Cutaneous T-Cell Lymphoma. J Cutan Med Surg 2004 Notes: In Press.
113 Lehrer MS, Crawford G, Gelfand J, Leyden JJ, Vittorio CC: The effect of wax epilation prior to hair removal with a long-pulsed alexandrite laser – a pilot study. J Dermatologic Surg 29: 118-123, 2003.
143 Prins C, Vittorio C, Padilla RS, Hunziker T, Itin P, Forster J, Brocker ED, Saurat JH, French LE: Effect of high-dose intravenous immunoglobulin therapy in Stevens-Johnson syndrome: a retrospective, multicenter study. Dermatology 207(1): 96-99, 2003.
134 Gelfand JM, Wasik MA, Vittorio CC, Rook AH, Junkins-Hopkins JM: Progressive epidermotropic primary cutaneous CD30+, CD8+ anaplastic large T-cell lymphoma in a patient with sarcoidosis. J Amer Acad Dermatol 51(2): 304-308, 2004 Notes:
14d Shapiro M, Wasik MA, Junkins-Hopkins JM, Rook AH, Vittorio CC, Itakura H, Frankel MC, Georgala S, Schuster SJ: Complete remission in advanced blastic NK-cell lymphoma/leukemia in elderly patients using the Hyper-CVAD regimen. Amer J Hematol 74(1): 46-51, 2003.
2c